Literature DB >> 20616743

Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.

Karen E Mark1, Anna Wald, Amalia S Magaret, Stacy Selke, Steven Kuntz, Meei-Li Huang, Lawrence Corey.   

Abstract

OBJECTIVE: To determine whether rapidly cleared episodes of herpes simplex virus (HSV) reactivation occur in HIV-infected adults.
METHODS: Twenty HSV-2-seropositive, HIV-seropositive adults, including 9 (45%) who were also HSV-1 seropositive, collected oral and anogenital swabs for HSV DNA polymerase chain reaction 4 times a day for 60 days. Samples were positive for HSV if we detected > or =150 copies of HSV DNA/mL of specimen.
RESULTS: Median HSV shedding episode duration was 7.5 (range 4-253) hours for oral and 11 (range 4-328) hours for anogenital reactivation. Thirty-five percent of oral and 29% of anogenital reactivations lasted < or =6 hours, and 59% of oral and 53% of anogenital reactivations lasted < or =12 hours. Seven of 9 participants who shed orally and 10 of 15 who shed anogenitally had > or =1 reactivation lasting < or =6 hours. The median maximum level of HSV DNA detected in an episode increased with episode duration for both oral and anogenital episodes. Concurrent oral and anogenital shedding occurred more frequently than expected: oral HSV shedding was detected on 17% of time points with anogenital but 1% of time points without anogenital, shedding (P < 0.001).
CONCLUSIONS: Rapidly cleared episodes of oral and anogenital HSV shedding occur in HIV-infected persons, supporting the hypothesis that frequent anogenital mucosal immune activation caused by HSV-2 is present in HIV coinfected persons, potentially contributing to HIV infectiousness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616743      PMCID: PMC3034443          DOI: 10.1097/QAI.0b013e3181d91322

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  19 in total

1.  Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa.

Authors:  Amalia S Magaret; Anna Wald; Meei-Li Huang; Stacy Selke; Larry Corey
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

2.  Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay.

Authors:  Lawrence Corey; Meei-Li Huang; Stacy Selke; Anna Wald
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

3.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Authors:  A Wald; L Corey; R Cone; A Hobson; G Davis; J Zeh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.

Authors:  H Nina Kim; Amalia Meier; Meei-Li Huang; Steve Kuntz; Stacy Selke; Connie Celum; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2006-07-12       Impact factor: 5.226

6.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

7.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

8.  Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.

Authors:  Jia Zhu; David M Koelle; Jianhong Cao; Julio Vazquez; Meei Li Huang; Florian Hladik; Anna Wald; Lawrence Corey
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

9.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

10.  Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.

Authors:  Jairam R Lingappa; Erin Kahle; Nelly Mugo; Andrew Mujugira; Amalia Magaret; Jared Baeten; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; M Essex; Edwin Were; Kenneth Fife; Guy Debruyn; Glenda Gray; James McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Robert W Coombs; Rhoda Morrow; William Whittington; Lawrence Corey; Anna Wald; Connie Celum
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more
  26 in total

1.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

2.  Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.

Authors:  Rachel A Bender Ignacio; Tara Perti; Amalia S Magaret; Sharanya Rajagopal; Claire E Stevens; Meei-Li Huang; Stacy Selke; Christine Johnston; Jeanne Marrazzo; Anna Wald
Journal:  J Infect Dis       Date:  2015-06-04       Impact factor: 5.226

3.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

4.  Herpes simplex virus genital infections: current concepts.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

5.  Current status and prospects for development of an HSV vaccine.

Authors:  Christine Johnston; David M Koelle; Anna Wald
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

6.  Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Authors:  Warren Phipps; Edith Nakku-Joloba; Elizabeth M Krantz; Stacy Selke; Meei-Li Huang; Fred Kambugu; Jackson Orem; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

7.  A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.

Authors:  Mayla Hsu; Meropi Aravantinou; Radhika Menon; Samantha Seidor; Daniel Goldman; Jessica Kenney; Nina Derby; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; Jose A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-22       Impact factor: 2.205

8.  High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.

Authors:  Tara Perti; Misty Saracino; Jared M Baeten; Christine Johnston; Kurt Diem; Negusse Ocbamichael; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

9.  Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.

Authors:  Darrell H S Tan; Janet M Raboud; Rupert Kaul; Sharon L Walmsley
Journal:  BMJ Open       Date:  2014-01-24       Impact factor: 2.692

10.  Primary Maternal Herpes Simplex Virus-1 Gingivostomatitis During Pregnancy and Neonatal Herpes: Case Series and Literature Review.

Authors:  Sara A Healy; Kathleen M Mohan; Ann J Melvin; Anna Wald
Journal:  J Pediatric Infect Dis Soc       Date:  2012-07-10       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.